A naukri.com initiative
Bioengineer
1w
222
Image Credit: Bioengineer
Dr. Jenny Chang, Renowned Cancer Clinician and Researcher, Appointed to Lead Houston Methodist Academic Institute
- Esteemed cancer clinician-scientist Dr. Jenny Chang has been appointed to lead the Houston Methodist Academic Institute.
- An exhaustive national search was conducted to identify a leader capable of succeeding Dr. H. Dirk Sostman.
- Dr. Chang is renowned for her groundbreaking work exploring mechanisms of therapy resistance in cancer stem cells.
- During her tenure, she has led transformative initiatives aimed at understanding the complex biology of cancer using advanced technologies.
- She has contributed to Dr. Mary and Ron Neal Cancer Center's rise to become one of the top 20 ranked cancer treatment facilities in the United States.
- Her leadership skills will guide the Academic Institute into a new era of research excellence, aiming towards becoming a beacon for research innovation.
- Dr. Chang's appointment comes after serving as the Academic Institute's Chief Clinical Science Officer and strengthening cancer clinical trials infrastructure across the Houston Methodist network.
- Her strategy aligns with Houston Methodist's mission of transforming patient care through research and innovation.
- Dr. Chang is committed to expanding clinical and translational research while enhancing cancer care and treatment across the facility's vast landscape.
- Her vision will steer the future of Houston Methodist Academic Institute towards groundbreaking research and enhanced therapeutic strategies.
Read Full Article
13 Likes
For uninterrupted reading, download the app